Healthcare -
Biotechnology - NASDAQ - US
$ 19.03
4.62 %
$ 14 B
Market Cap
-82.74
P/E
SMMT - SHORT-TERM DEBT
Short-term Debt SMMT - Summit Therapeutics Inc.
2.81 M
LAST VALUE
60.46%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR